Lab21 launches diagnostic testing for lung cancer patients

Lab21 has launched a new companion diagnostic testing service for non-small cell lung cancer patients, to be operated from its laboratories in Cambridge. The EML4-ALK companion diagnostic test for translocations in the ALK gene is designed to help ...
See all stories on this topic » Tags: ALK, CAMBRIDGE, cell lung cancer, companion, lab, lung cancer patients, new companion, non small cell lung cancer, service, small cell lung cancer, testing

Related Articles

• New Lung Cancer Companion Diagnostic Service Launched by Lab21
• Diagnostic BioSystems Launches the First Automated IHC Multiplex Platform for …
• Group launches website for international mesothelioma patients
• LabCorp To Offer a New Companion Diagnostic for Non-Small Cell Lung Cancer
• AstraZeneca Paying for Genetic Testing Services for UK Lung Cancer Patients …
• Diagnostic BioSystems Launches the First Automated IHC Multiplex Platform for …
• Mesothelioma Diagnosis: New Diagnostic Test may Benefit Mesothelioma Patients – Asbestos.com
• The Importance of Asbestos Testing
• Mesothelioma-Aid.Org Launches New Page: Pleural Mesothelioma Symptoms
• Biomoda Extends Pilot Trial on Lung Cancer Diagnostic